TAP Execs Acquitted Of Conspiracy Charges Related To Marketing Practices
Executive Summary
The acquittal of eight current and former TAP employees on conspiracy charges suggests that the perception of shifting standards for marketing compliance will make it difficult for prosecutors to translate corporate settlements into convictions of individual executives
You may also be interested in...
Takeda hires compliance officer
Takeda Pharmaceuticals has hired Jeanine Jiganti as the company's chief compliance officer. Jiganti, formerly with the Illinois Department of Commerce and Economic Opportunity, will advise senior management on compliance and regulatory issues and promote compliance with applicable laws and company policies. Takeda's joint venture with Abbott, TAP, reached a settlement with federal prosecutors in 2001 to resolve allegations of violations of the Prescription Drugs Marketing Act and the False Claims Act (1"The Pink Sheet" July 19, 2004, p. 14)...
Takeda hires compliance officer
Takeda Pharmaceuticals has hired Jeanine Jiganti as the company's chief compliance officer. Jiganti, formerly with the Illinois Department of Commerce and Economic Opportunity, will advise senior management on compliance and regulatory issues and promote compliance with applicable laws and company policies. Takeda's joint venture with Abbott, TAP, reached a settlement with federal prosecutors in 2001 to resolve allegations of violations of the Prescription Drugs Marketing Act and the False Claims Act (1"The Pink Sheet" July 19, 2004, p. 14)...
Serostim Sales Plan Included Physician Kickbacks, Government Alleges
Serono sales managers created a plan offering physicians financial incentives to prescribe Serostim in numbers needed to achieve sales goals, an information filed by Boston U.S. Attorney Michael Sullivan alleges